封面
市场调查报告书
商品编码
1981021

全球食物过敏诊断和治疗市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Food Allergy Diagnostics And Therapeutics Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计食品过敏诊断和治疗市场将从 2025 年的 100.1 亿美元成长到 2034 年的 208.5 亿美元,2026 年至 2034 年的复合年增长率为 8.49%。

随着全球食物过敏盛行率的上升,食物过敏诊断和治疗的全球市场正在迅速扩张。对花生、牛奶、鸡蛋和贝类等食物的过敏反应越来越常见,尤其是在儿童身上。这一日益严重的健康问题推动了对精准诊断测试和有效治疗方案的需求,以控制和预防严重的过敏反应。

诊断技术的进步在提高过敏检测的准确性方面发挥了至关重要的作用。血液检测、皮肤点刺试验和分子诊断工具正在帮助医疗专业人员更准确地识别特定过敏原。同时,研究人员正在探索创新的治疗方法,例如免疫疗法和生物疗法,旨在随着时间的推移降低过敏易感性。

随着全球对食物过敏的认识不断提高,预计未来市场将持续成长。世界各国政府和医疗机构都在积极推广早期诊断和管理策略,以减少过敏相关併发症。新兴国家对过敏治疗的持续研究以及医疗服务的拓展,将为市场的长期成长提供支撑。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球食物过敏诊断与治疗市场:依产品划分

  • 市场分析、洞察与预测
  • 诊断
  • 治疗药物

第五章 全球食物过敏诊断与治疗市场:依过敏原类型划分

  • 市场分析、洞察与预测
  • 花生
  • 牛奶
  • 甲壳类动物
  • 坚果和种子
  • 小麦
  • 大豆
  • 其他的

第六章:全球食物过敏诊断与治疗市场:依最终用途划分

  • 市场分析、洞察与预测
  • 医院和诊所
  • 学术研究机构
  • 诊断检测实验室

第七章 全球食物过敏诊断与治疗市场:按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Astellas Pharma Inc
    • Aimmune Therapeutics
    • Meridian Medical Technologies
    • Medeca Pharma AB
    • BioMAfA(C)Rieux SA
    • Omega Diagnostics Group PLC
    • Camallergy(Cambridge Allergy Ltd)
    • Immunomic Therapeutics Inc
    • Prota Therapeutics Pty Ltd
    • ALK-AbellAfA3 A/S
    • HYCOR Biomedical
    • HOB Biotech Group Corp. Ltd
简介目录
Product Code: VMR112115563

The Food Allergy Diagnostics And Therapeutics Market size is expected to reach USD 20.85 Billion in 2034 from USD 10.01 Billion (2025) growing at a CAGR of 8.49% during 2026-2034.

The global food allergy diagnostics and therapeutics market is expanding rapidly due to the increasing prevalence of food allergies worldwide. Allergic reactions to foods such as peanuts, milk, eggs, and shellfish have become more common, particularly among children. This growing health concern is driving demand for accurate diagnostic tests and effective therapeutic solutions to manage and prevent severe allergic reactions.

Advancements in diagnostic technologies are playing a crucial role in improving allergy detection. Blood tests, skin prick tests, and molecular diagnostic tools are helping healthcare professionals identify specific allergens more accurately. At the same time, researchers are exploring innovative treatment approaches such as immunotherapy and biologic therapies that aim to reduce allergic sensitivity over time.

Future growth in the market is expected as awareness about food allergies continues to increase globally. Governments and healthcare organizations are promoting early diagnosis and improved management strategies to reduce allergy-related complications. Continuous research in allergy therapeutics and expanding healthcare services in emerging economies will likely support long-term market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Diagnostics
  • Therapeutics

By Allergen Source

  • Peanuts
  • Milk
  • Eggs
  • Fish
  • Shellfish
  • Tree Nuts
  • Wheat
  • Soy
  • Others

By End-use

  • Hospitals And Clinics
  • Academic Research Institutes
  • Diagnostics Laboratories

COMPANIES PROFILED

  • Astellas Pharma Inc, Aimmune Therapeutics, Meridian Medical Technologies, Medeca Pharma AB, bioMrieux SA, Omega Diagnostics Group PLC, Camallergy Cambridge Allergy Ltd, Immunomic Therapeutics Inc, Prota Therapeutics Pty Ltd, ALKAbell AS, HYCOR Biomedical, HOB Biotech Group Corp Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY ALLERGEN SOURCE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Allergen Source
  • 5.2. Peanuts Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Milk Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Eggs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Fish Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Shellfish Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Tree Nuts Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Wheat Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.9. Soy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Allergen Source
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Allergen Source
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Allergen Source
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Allergen Source
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Allergen Source
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Astellas Pharma Inc
    • 9.2.2 Aimmune Therapeutics
    • 9.2.3 Meridian Medical Technologies
    • 9.2.4 Medeca Pharma AB
    • 9.2.5 BioMAfA(C)Rieux SA
    • 9.2.6 Omega Diagnostics Group PLC
    • 9.2.7 Camallergy (Cambridge Allergy Ltd)
    • 9.2.8 Immunomic Therapeutics Inc
    • 9.2.9 Prota Therapeutics Pty Ltd
    • 9.2.10 ALK-AbellAfA3 A/S
    • 9.2.11 HYCOR Biomedical
    • 9.2.12 HOB Biotech Group Corp. Ltd